The rapid pathogen detection in USA market is expected to increase by USD 178 million, at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2028, according to the latest edition of the Rapid Pathogen Detection Market in USA Report.
This industry report offers market estimates of the USA market, followed by a detailed analysis of the product, and testing method. The USA market data on rapid pathogen detection can be segmented by product: detection devices, sensors. According to the research, the detection devices segment had the largest share in the rapid pathogen detection market in USA. Rapid pathogen detection market is further segmented by testing method: immunological analysis, mass spectrometry, polymerase chain reaction (PCR). In 2021, the immunological analysis segment made up the largest share of revenue generated by the rapid pathogen detection market.
The detection device market is further segmented into handheld, installed, portable, tabletop. Gen Consulting Company research indicates that the handheld segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years.
The USA rapid pathogen detection market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players ANP Technologies Inc., Battelle, Bavarian Nordic A/S, bioMérieux Inc., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, GlaxoSmithKline plc (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, Merck KGaA, Novavax Inc., Soligenix Inc., Thermo Fisher Scientific Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the USA Rapid Pathogen Detection Market
– Identify segments/areas to invest in over the forecast period in the USA Rapid Pathogen Detection Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 6.8% |
| Pages | 23 |
| Key Players | ANP Technologies Inc., Battelle, Bavarian Nordic A/S, BioMerieux S.A., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, GlaxoSmithKline plc (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, Merck KGaA, Novavax Inc., Soligenix Inc., Thermo Fisher Scientific Inc. |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.
